Torrent Pharma’s FY 2024-25 Social Responsibility Mandate Exceeded, With Surplus Earmarked for Long-Term Community Impact
NEW DELHI (India CSR): In the financial year 2024-25, Torrent Pharmaceuticals Limited (Torrent Pharma) once again demonstrated its leadership in responsible corporate citizenship. The company not only surpassed its statutory Corporate Social Responsibility (CSR) spending mandate but also displayed transparent governance by allocating Rs 10.78 crores of unspent funds to ongoing projects. Far from signaling inaction, this earmarked amount reflects the pharmaceutical giant’s commitment to long-term social initiatives, ensuring uninterrupted execution of multi-year programs.
At the heart of Torrent Pharma’s CSR vision is its philosophy of “Happiness for All.” The company believes that financial performance is incomplete without parallel contributions to community well-being. In FY 2024-25, Torrent spent Rs 35.03 crores on CSR activities, surpassing its statutory requirement of Rs 33.31 crores, while also transferring unspent funds for future projects—an approach that reflects integrity, foresight, and compliance with the Companies Act, 2013.
The Statutory CSR Mandate
Torrent Pharmaceuticals, India’s 7th largest pharmaceutical company, calculated its CSR obligations based on the average net profit of the previous three financial years, which stood at Rs 1,665.67 crores.
- 2% Statutory Requirement: Rs 33.31 crores
- Carried Forward Surplus from Past Years: ₹0.16 crore
- Total CSR Obligation for FY 2025: Rs 33.47 crores
The company ultimately spent Rs 35.03 crores, going beyond its legal duty. However, Rs 10.78 crores was formally transferred into the Unspent CSR Account in April 2025, earmarked for long-term ongoing projects.
Understanding the Rs 10.78 Crores Unspent Allocation
In corporate CSR reporting, “unspent” can easily be misunderstood. At Torrent Pharma, this figure does not mean neglect or underperformance. Instead, it refers to carefully budgeted amounts that have been set aside for multi-year projects requiring sustained funding.
- Unspent Amount: Rs10.78 crores
- Transferred on: April 28, 2025
- Compliance: Section 135(6) of Companies Act, 2013
- Purpose: Funding approved ongoing projects such as advanced healthcare and green infrastructure
This transfer ensures that projects already underway will continue without disruption. It also guarantees transparency, as the Companies Act requires such allocations to be placed in a separate bank account within 30 days of the financial year’s end.
Additionally, Torrent Pharma utilized Rs 11.78 crores during FY 2025 that originated from previously unspent allocations, thereby demonstrating that earmarked funds are consistently mobilized to achieve impact.
Flagship Healthcare Initiative: REACH
Torrent Pharma’s flagship CSR program, REACH (Reach EAch CHild), remained the most significant beneficiary of its CSR funding, including allocations from both current spending and ongoing project accounts.
UNM Children Hospital – A Centre of Excellence
At the heart of REACH is the UNM Children Hospital in Kamrej, Gujarat, which absorbed Rs19.59 crores in FY 2025. The hospital has become a premier center for advanced paediatric healthcare in India.
Key upgrades included:
- A Linde liquid oxygen tank for uninterrupted oxygen supply.
- A new modular operating theatre with a Carl Zeiss TIVATO 700 microscope for critical surgeries.
- NABL certification for diagnostic services, ensuring world-class standards.
- Acquisition of vital capital assets: hospital building (Rs 50.01 lakhs), ICU ambulance (Rs 57.28 lakhs), and medical equipment.
Rural Outreach through Screening Camps
Beyond the hospital’s premises, Torrent conducted surgical screening camps in Narmada, Chhota Udepur, Naswadi, and Sagbara districts. These camps reached 2,100 villages, providing medical access to children suffering from malnutrition, anaemia, and congenital disorders.
This multi-year healthcare initiative is one of the projects backed by unspent allocations, ensuring continuity of critical services.
Green and Social Infrastructure: Pratiti
Torrent Pharma also dedicated Rs 12.48 crores to Pratiti – Public Park Development (Phase III), with some components planned as ongoing projects financed from unspent allocations.
Urban Parks and Water Conservation
The initiative created and rejuvenated public gardens, lakes, and ponds, improving air quality, reducing noise pollution, and recharging groundwater in urban neighborhoods.
Local Development near Manufacturing Plants
The company invested:
- Rs 1.11 crores in Sikkim for school and panchayat infrastructure.
- Rs 1 crore in Baddi for school and community development.
- Rs 0.10 crores across Dahej, Vizag, and Pithampur for local upgrades.
Some of these initiatives fall under multi-year commitments funded through the Rs 10.78 crore unspent allocation, ensuring continuity.
PAGE Foundation – Building Pharma Talent
Torrent also contributed Rs 0.27 crores to the PAGE Foundation (Pharmaceutical Academy for Global Excellence), a long-term initiative by the Indian Pharmaceutical Alliance.
- Budgeted Allocation: ₹10 crores for FY 2025
- Utilized in FY 2025: ₹0.27 crores
- Purpose: Land acquisition in Hyderabad for a dedicated skilling institute
This initiative is also supported by unspent CSR allocations, reflecting the company’s forward-looking vision for India’s pharma talent pool.
Asset Creation Through CSR
Torrent Pharma reported the creation of 90 capital assets through CSR expenditure in FY 2025. These assets—funded both through annual spends and unspent allocations—include:
- Healthcare Infrastructure: ICU ambulance, paediatric hospital building, audiology equipment, surgical tools.
- Education and Rural Assets: Computers for PHCs, electrical installations in Gujarat villages, water ATMs in Gangtok.
- Community Assets: Civil works for schools and water supply systems in rural Sikkim.
The continuity of such asset creation depends on earmarked unspent funds, highlighting why the Rs 10.78 crore allocation is crucial for long-term impact.
CSR Spending and Unspent Funds – Snapshot
| Category | Amount (₹ Crores) | Remarks |
|---|---|---|
| Statutory Obligation | 33.31 | As per 2% of net profit |
| Obligation Including Carry Forward | 33.47 | Added ₹0.16 crore |
| Actual CSR Spending | 35.03 | Exceeded mandate |
| Unspent Amount (Transferred) | 10.78 | For ongoing projects |
| Utilized from Previous Unspent Funds | 11.78 | Applied in FY 2025 |
Governance, Compliance, and Accountability
Torrent Pharma’s management of CSR demonstrates best-in-class governance. By transferring Rs 10.78 crores into a dedicated unspent account, the company complied with legal mandates while ensuring that long-term projects such as REACH and Pratiti continue seamlessly.
This approach assures stakeholders that every rupee earmarked for CSR is traceable, accountable, and aligned with sustainable development objectives.
Why the Unspent Amount Matters
The unspent allocation is not a shortfall—it is a sign of foresight. By securing Rs 10.78 crores for ongoing projects, Torrent Pharma guarantees continuity of healthcare, education, and community programs that require multiple years of investment.
This demonstrates that Torrent Pharma views CSR as a long-term partnership with society, rather than a year-to-year obligation.
You Learn
Torrent Pharmaceuticals’ CSR journey in FY 2024-25 highlights a dual achievement: exceeding its statutory CSR mandate with Rs 35.03 crores spent, and responsibly managing Rs 10.78 crores of unspent funds for ongoing initiatives. By channeling resources into advanced paediatric healthcare, sustainable community development, and educational infrastructure, the company has reinforced its philosophy of “Happiness for All.”
In doing so, Torrent Pharma not only complies with the law but also sets a benchmark in CSR transparency, governance, and long-term social investment—a model other corporates can emulate
(India CSR)
ALSO READ | Torrent Pharmaceuticals CSR Spending Report of Over Rs 35 Crore for FY 2025
